ASHLEE DOUGHERTY: Open Payments
NPI 1801416599 · MEXICO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$135 in 7 payments from 6 companies in 2025. Trend: 2023 $277 · 2024 $94 · 2025 $135
Food & beverage: $135
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Dexcom, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: REXULTI, Dexcom G6 Transmitter, VRAYLAR, FARXIGA, MOUNJARO, BREZTRI, VOQUEZNA.
Industry payments across MO — which companies pay providers there.
